dBMEDx, a Colorado-based medical device company, won the $7,500 first prize at the 2014 Venture Showcase competition held at the BioWest Conference & Expo. The competition featured three finalists who presented their technologies and business plans to a panel of judges and investors. dBMEDx is developing clinical monitoring devices using patented, non-invasive ultrasound scanning technology to provide automated diagnostic measurements without extensive training.

1. dBMEDx Wins the Venture Showcase Competition at BioWest 2014
dBMEDx (Littleton, CO) won the Venture Showcase competition at the 2014 BioWest Conference &
Expo, which is organized by the Colorado BioScience Association (CBSA). Three finalists competed for
the $7,500 cash prize, presenting their technologies and business plans in front of a live audience to a
panel of bioscience experts and venture capitalists.
Denver, CO, September 11, 2014 – dBMEDx (Littleton) won the 2014 Venture Showcase competition at the
BioWest Conference & Expo yesterday at the Marriott City Center Denver, receiving the $7,500 cash prize. The
announcement is made by April Giles, Colorado BioScience Association (CBSA) President & CEO who says, “We are
very proud to announce dBMEDx as the winner of the Venture Showcase. The check presentation was an exciting
end to the BioWest Conference. The award not only includes the cash prize of $7,500 but also includes recognition
and exposure for the company. ” This award is sponsored by Dorsey & Whitney LLP and The Metro Denver
Economic Development Corporation. BioWest, the Rocky Mountain Region's premier medical device and
biotechnology conference, is organized by the CBSA and held every other year.
dBMEDx is a Colorado‐based medical device development company that is creating
clinical decision and patient monitoring devices using its patented, non‐invasive
scanning technology. These devices combine the power and safety of ultrasound
with sophisticated image processing electronics and software to provide simple, fully
automated and completely noninvasive diagnostic measurements. Fully automated
means that very little training is required and the user does not need any experience
with ultrasound to use our devices. To enable this level of automation, dBMEDx has
successfully created and patented an extremely compact, wireless, 3D scan engine.
The scan engine, which can be held in the palm of the hand, includes a complete 3D ultrasound imaging machine
and automated image processor within a small, sealed tube. The system also includes an integrated Bluetooth
radio and rechargeable battery, which is inductively charged. The company is in the process of commercializing the
first application for this technology, the BBS Revolution™ device for automated bladder volume measurement, and
has a range of pipeline of products for other clinical applications as well. Visit: http://www.dbmedx.com.
The Venture Showcase format allowed each company’s lead executive (dBMEDx CEO
David Shine is pictured here) to make a 15‐minute presentation with an
accompanying slide deck explaining their technology and business plan to a panel of
judges in front of a live audience. This year's judging panel included the following:
• Michael Weiner, Partner, Dorsey
• Ned Scheetz, Managing Director, Aphelion Capital
• Steve VanNurden, President & CEO, Fitzsimons Redevelopment Authority
‐More‐

2. Page 2
The three 2014 Venture Showcase finalists included:
dBMEDx – Littleton http://www.dbmedx.com
KromaTiD, Inc. ‐ Fort Collins http://www.kromatid.com
Mighty Oak Medical – Englewood http://www.mightyoakmedical.com
The BioWest Conference was attended by more than 300 industry leaders, government representatives, executives,
researchers, investors and entrepreneurs. “We look forward to the continued growth of the bioscience industry and
presenting the conference in again 2016,” Giles concludes.
About Colorado BioScience Association
CBSA is a not‐for‐profit organization providing services and support for Colorado's bioscience industry. With more
than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business
environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry
in the state, and speaking with a single voice on behalf of the industry. For more information, visit
http://www.cobioscience.com.
CBSA also is found on these social media sites:
Twitter: http://www.twitter.com/COBioscience
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation
Blogger: http://coloradobio.blogspot.com
YouTube: http://www.youtube.com/COBioscience
Pinterest: http://pinterest.com/COBioscience
Google+: https://plus.google.com/u/0/101998361861247247369/posts
Tumblr: http://cobioscience.tumblr.com
Instagram: http://instagram.com/coloradobioscience
Contact:
Maggie Chamberlin Holben, APR, Absolutely Public Relations ‐ http://www.absolutelypr.com ‐ 303‐984‐9801,
maggie@absolutelypr.com